Carbon-Negative Supply-Chain Enablers
This carefully selected group of stocks represents companies building our carbon-negative future. Professional analysts have identified these firms as leaders in technologies that permanently remove CO₂ from the atmosphere, positioning them to benefit from the growing demand for verifiable carbon removal solutions.
Top Picks from This Group
Here are a few of the assets in this group. Create an account to unlock the full list.
About This Group of Stocks
Our Expert Thinking
This portfolio targets the rising economic value of carbon dioxide removal. As companies worldwide pursue ambitious climate goals, these technologies are becoming essential infrastructure for achieving net-zero targets. The portfolio focuses on firms commercializing permanent carbon capture solutions like direct-air-capture and mineralization.
What You Need to Know
These companies represent high-growth opportunities in the emerging carbon removal market. The sector is gaining momentum from corporate climate pledges, evolving regulations, and rising carbon prices. Consider this a satellite position in a diversified portfolio, as these cutting-edge technologies come with both innovation potential and implementation risks.
Why These Stocks
Each company was selected for its core focus on developing and deploying carbon removal technologies. The curation prioritizes pure-play developers and project operators whose business models center on scalable, permanent carbon sequestration. New government incentives and market demand are making the economics increasingly attractive.
12 Month Growth Potential
Use the growth calculator to see how much investing in these assets could return over one year.
If you invested across these assets:
in 12 months it could be worth:
+330.37%
Group Performance Snapshot
Average 12 Month Profit
On average, analysts expect assets in this group to grow 330.37% over the next year.
Stocks Rated Buy by Analysts
11 of 14 assets in this group are rated Buy by professional analysts.
Group Growth vs Bank interest
This group averaged a 446.6% return last month, beating the typical 4% bank rate.
Why You'll Want to Watch These Stocks
Climate Regulation Tailwinds
As governments worldwide strengthen climate policies, companies with proven carbon removal technologies are positioned to benefit from new incentives and mandates that reward permanent CO2 sequestration.
Carbon Credit Gold Rush
The voluntary carbon market is expected to grow 15x by 2030, with high-quality removal credits commanding premium prices. These companies are at the forefront of supplying this increasingly valuable commodity.
Early-Mover Advantage
These pioneers are scaling technologies that could become essential infrastructure for the net-zero economy. Getting in now means potential exposure to the birth of a trillion-dollar industry.
Why Invest with Nemo Money?
Zero Commission
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Trusted & Regulated
Part of Exinity Group 2015, serving over a million customers globally.
6% Interest on Cash
Earn 6% AER on uninvested cash with daily interest payments.
Discover More Opportunities
Beyond The App Store: Europe's New Rules
Following regulatory pressure from the European Union, Google has revised its Play Store rules to permit alternative payment systems. This change creates a new investment opportunity in companies poised to benefit from a more open mobile app ecosystem.
The New Cost of Compliance: Investing in HR Tech
Australian airline Qantas received a historic $58 million fine for unlawfully dismissing workers, setting a new precedent for corporate accountability in labor practices. This ruling creates an investment opportunity in companies that provide the essential HR, legal, and compliance technologies businesses now need to navigate stricter labor law enforcement.
GLP-1s Target Liver Disease
The FDA's approval of Wegovy for a serious liver disease has boosted Novo Nordisk's market position and highlighted a major new application for GLP-1 drugs. This development creates an investment opportunity in companies focused on innovative treatments for metabolic and liver-related conditions.
Frequently Asked Questions
Everything you need to know about the product and billing.